| Literature DB >> 25362717 |
Alexis Ogdie1, Sergio Schwartzman1, Lihi Eder1, Ajesh B Maharaj1, Devy Zisman1, Siba P Raychaudhuri1, Soumya M Reddy1, Elaine Husni2.
Abstract
Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis that can lead to decreased health-related quality of life and permanent joint damage leading to functional decline. In addition to joint and skin manifestations, both psoriasis and PsA are associated with numerous comorbidities and extraarticular/cutaneous manifestations, which may influence the physician's choice of therapy. The objectives of this review are (1) to identify comorbidities in patients with PsA based on the available evidence; (2) to examine the effects of these comorbidities or extraarticular/cutaneous manifestation on the management of patients with PsA as well as the selection of therapy; and (3) to highlight research needs around comorbidities and treatment paradigms. This review is part of a treatment recommendations update initiated by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).Entities:
Keywords: AUTOIMMUNE OPHTHALMIC DISEASE; CARDIOVASCULAR DISEASE; DIABETES; METABOLIC SYNDROME; OBESITY; OSTEOPOROSIS
Mesh:
Year: 2014 PMID: 25362717 DOI: 10.3899/jrheum.140882
Source DB: PubMed Journal: J Rheumatol ISSN: 0315-162X Impact factor: 4.666